Meeting
2020 ASCO Virtual Scientific Program
Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients.
Authors
Xin Huang
Peking Union Medical College Hospital, Beijing, China
Xin Huang , Huanwen M. Wu , Changbin Zhu , Di Shao , Dan Guo , Yidong Zhou , Yan Lin , Chang Chen , Ying Xu , Bin Zhao , Yu Song , Tao Lu , Qiang Sun
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 558)
DOI
10.1200/JCO.2020.38.15_suppl.558
Abstract #
558
Poster Bd #
50
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Frequency of brain metastases in patients with locally advanced triple negative breast cancer after neoadjuvant platinum-based chemotherapy: Impact of BRCA1/2 mutations.
First Author: Elena Glazkova
Poster
2020 ASCO Virtual Scientific Program
The incidence and impact of brain metastasis in patients with hereditary BRCA1/2 mutated invasive breast cancer in a prospectively followed cohort.
First Author: Haven Garber
Poster
2018 ASCO Annual Meeting
A phase II clinical trial to analyze olaparib response in patients with BRCA1 and/or BRCA2 promoter methylation with advanced breast cancer (GEICAM/2015-06 COMETA-Breast study).
First Author: Juan De La Haba
Poster
2015 ASCO Annual Meeting
Impact of prior knowledge of mutation status on tumor stage in BRCA1/2 mutation carriers with newly diagnosed breast cancer.
First Author: Clinton Yam